Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity

About the Report

About the Report

Global oral antibiotics market will reach USD 26.67 billion by 2030, growing by 4.0% annually over 2020-2030 driven by rising complications associated with COVID-19 epidemic, development of innovative antibiotics, and growing healthcare expenditure.

Highlighted with 89 tables and 97 figures, this 187-page report Global Oral Antibiotics Market 2020-2030 by Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire global oral antibiotics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

Market Structure

Growth Drivers

Restraints and Challenges

Emerging Product Trends & Market Opportunities

Porter's Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global oral antibiotics market in every aspect of the classification from perspectives of Drug Class, Action Mechanism, Drug Origin, Activity Spectrum, Application, Drug Type, and Region.

Based on Drug Class, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Cephalosporin

Cefuroxime Axetil

Cephalexin

Cefixime

Cefpodoxime

Other Cephalosporin

Penicillin

Macrolides

Tetracycline

Quinolones

Sulfonamides

Aminoglycosides

Other Drug Classes

Based on Action Mechanism, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Cell Wall Synthesis Inhibitors

Mycolic Acid Inhibitors

RNA Synthesis Inhibitors

DNA Synthesis Inhibitors

Protein Synthesis Inhibitors

Other Mechanisms

Based on Drug Origin, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Natural Antibiotics

Semi-synthetic Antibiotics

Synthetic Antibiotics

Based on Activity Spectrum, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Broad-spectrum Antibiotics

Narrow-spectrum Antibiotics

Based on Application, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Urinary Tract Infections (UTIS)

Upper Respiratory Tract Infections (URTI)

Lower Respiratory Tract Infections (LRTIs)

Dental Infections

Monotherapies

Combined Therapies

Respiratory Tract Infections (RTIS)

Other Applications

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

Brand Antibiotics

Generic Antibiotics

Geographically, the following regions together with the listed national/local markets are fully investigated:

APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)

Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

North America (U.S., Canada, and Mexico)

South America (Brazil, Chile, Argentina, Rest of South America)

RoW (Saudi Arabia, UAE, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Class, Drug Origin, and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global oral antibiotics market are assayed quantitatively and qualitatively through GMD's Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

Astellas Pharma

AstraZeneca Plc

Bayer AG

Bristol Myers Squibb Company

Cipla Inc.

Dr. Reddy's Laboratories Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

Mayne Pharma Group Ltd.

MELINTA THERAPEUTICS, INC.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Products


Companies

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories

Astellas Pharma

AstraZeneca Plc

Bayer AG

Bristol Myers Squibb Company

Cipla Inc.

Dr. Reddy's Laboratories Ltd.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gilead Sciences, Inc.

GlaxoSmithKline plc.

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals)

Mayne Pharma Group Ltd.

MELINTA THERAPEUTICS, INC.

Merck KGaA

Novartis AG

Pfizer Inc.

Sanofi

Sun Pharmaceutical Industries Ltd.

Table of Contents

Table of Contents

1 Introduction 10

1.1 Industry Definition and Research Scope 10

1.1.1 Industry Definition 10

1.1.2 Research Scope 11

1.2 Research Methodology 14

1.2.1 Overview of Market Research Methodology 14

1.2.2 Market Assumption 15

1.2.3 Secondary Data 15

1.2.4 Primary Data 15

1.2.5 Data Filtration and Model Design 17

1.2.6 Market Size/Share Estimation 18

1.2.7 Research Limitations 19

1.3 Executive Summary 20

2 Market Overview and Dynamics 23

2.1 Market Size and Forecast 23

2.1.1 Impact of COVID-19 on the Market 24

2.2 Major Growth Drivers 26

2.3 Market Restraints and Challenges 30

2.4 Emerging Opportunities and Market Trends 33

2.5 Porter's Fiver Forces Analysis 37

3 Segmentation of Global Market by Drug Class 41

3.1 Market Overview by Drug Class 41

3.2 Cephalosporin 43

3.3 Penicillin 45

3.4 Macrolides 46

3.5 Tetracycline 47

3.6 Quinolones 48

3.7 Sulfonamides 49

3.8 Aminoglycosides 50

3.9 Other Drug Classes 51

4 Segmentation of Global Market by Action Mechanism 52

4.1 Market Overview by Action Mechanism 52

4.2 Cell Wall Synthesis Inhibitors 54

4.3 Mycolic Acid Inhibitors 55

4.4 RNA Synthesis Inhibitors 56

4.5 DNA Synthesis Inhibitors 57

4.6 Protein Synthesis Inhibitors 58

4.7 Other Mechanisms 59

5 Segmentation of Global Market by Drug Origin 60

5.1 Market Overview by Drug Origin 60

5.2 Natural Antibiotics 62

5.3 Semi-synthetic Antibiotics 63

5.4 Synthetic Antibiotics 64

6 Segmentation of Global Market by Activity Spectrum 65

6.1 Market Overview by Activity Spectrum 65

6.2 Broad-spectrum Antibiotics 67

6.3 Narrow-spectrum Antibiotics 68

7 Segmentation of Global Market by Application 69

7.1 Market Overview by Application 69

7.2 Urinary Tract Infections (UTIS) 71

7.3 Dental Infections 72

7.3.1 Monotherapies for Dental Infections 73

7.3.2 Combined Therapies for Dental Infections 74

7.4 Respiratory Tract Infections (RTIS) 75

7.4.1 Upper Respiratory Tract Infections (URTI) 76

7.4.2 Lower Respiratory Tract Infections (LRTIs) 77

7.5 Other Applications 78

8 Segmentation of Global Market by Drug Type 79

8.1 Market Overview by Drug Type 79

8.2 Brand Antibiotics 81

8.3 Generic Antibiotics 82

9 Segmentation of Global Market by Region 83

9.1 Geographic Market Overview 2019-2030 83

9.2 North America Market 2019-2030 by Country 89

9.2.1 Overview of North America Market 89

9.2.2 U.S. 93

9.2.3 Canada 97

9.2.4 Mexico 99

9.3 European Market 2019-2030 by Country 101

9.3.1 Overview of European Market 101

9.3.2 Germany 105

9.3.3 UK 107

9.3.4 France 109

9.3.5 Spain 111

9.3.6 Italy 113

9.3.7 Russia 115

9.3.8 Rest of European Market 117

9.4 Asia-Pacific Market 2019-2030 by Country 119

9.4.1 Overview of Asia-Pacific Market 119

9.4.2 Japan 123

9.4.3 China 126

9.4.4 Australia 128

9.4.5 India 130

9.4.6 South Korea 132

9.4.7 Rest of APAC Region 134

9.5 South America Market 2019-2030 by Country 136

9.5.1 Argentina 139

9.5.2 Brazil 141

9.5.3 Chile 143

9.5.4 Rest of South America Market 145

9.6 MEA Market 2019-2030 by Country 146

9.6.1 UAE 149

9.6.2 Saudi Arabia 151

9.6.3 South Africa 153

9.6.4 Other National Markets 155

10 Competitive Landscape 156

10.1 Overview of Key Vendors 156

10.2 New Product Launch, Partnership, Investment, and M&A 160

10.3 Company Profiles 161

Abbott Laboratories 161

Astellas Pharma 163

AstraZeneca Plc 164

Bayer AG 165

Bristol Myers Squibb Company 166

Cipla Inc. 167

Dr. Reddy's Laboratories Ltd. 168

Eli Lilly and Company 169

F. Hoffmann-La Roche Ltd. 170

Gilead Sciences, Inc. 171

GlaxoSmithKline plc. 172

Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals) 173

Mayne Pharma Group Ltd. 174

MELINTA THERAPEUTICS, INC. 175

Merck KGaA 176

Novartis AG 177

Pfizer Inc. 178

Sanofi 179

Sun Pharmaceutical Industries Ltd. 180

11 Investing in Global Market: Risk Assessment and Management 181

11.1 Risk Evaluation of Global Market 181

11.2 Critical Success Factors (CSFs) 184

Related Reports and Products 187


List of Figure

Figure 1. Research Method Flow Chart 14

Figure 2. Breakdown of Primary Research 16

Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 18

Figure 4. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 20

Figure 5. Global Oral Antibiotics Market, 2019-2030, USD mn 23

Figure 6. Impact of COVID-19 on Business 24

Figure 7. Primary Drivers and Impact Factors of Global Oral Antibiotics Market 26

Figure 8. GDP per capita in the World, 1960-2018, USD thousand 29

Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 29

Figure 10. Primary Restraints and Impact Factors of Global Oral Antibiotics Market 30

Figure 11. Investment Opportunity Analysis 34

Figure 12. Porter's Fiver Forces Analysis of Global Oral Antibiotics Market 37

Figure 13. Breakdown of Global Oral Antibiotics Market by Drug Class, 2019-2030, % of Revenue 42

Figure 14. Global Addressable Market Cap in 2020-2030 by Drug Class, Value (USD mn) and Share (%) 42

Figure 15. Global Oral Antibiotics Market: Cephalosporin, 2019-2030, USD mn 43

Figure 16. Global Oral Antibiotics Market: Penicillin, 2019-2030, USD mn 45

Figure 17. Global Oral Antibiotics Market: Macrolides, 2019-2030, USD mn 46

Figure 18. Global Oral Antibiotics Market: Tetracycline, 2019-2030, USD mn 47

Figure 19. Global Oral Antibiotics Market: Quinolones, 2019-2030, USD mn 48

Figure 20. Global Oral Antibiotics Market: Sulfonamides, 2019-2030, USD mn 49

Figure 21. Global Oral Antibiotics Market: Aminoglycosides, 2019-2030, USD mn 50

Figure 22. Global Oral Antibiotics Market: Other Drug Classes, 2019-2030, USD mn 51

Figure 23. Breakdown of Global Oral Antibiotics Market by Action Mechanism, 2019-2030, % of Sales Revenue 53

Figure 24. Global Addressable Market Cap in 2020-2030 by Action Mechanism, Value (USD mn) and Share (%) 53

Figure 25. Global Oral Antibiotics Market: Cell Wall Synthesis Inhibitors, 2019-2030, USD mn 54

Figure 26. Global Oral Antibiotics Market: Mycolic Acid Inhibitors, 2019-2030, USD mn 55

Figure 27. Global Oral Antibiotics Market: RNA Synthesis Inhibitors, 2019-2030, USD mn 56

Figure 28. Global Oral Antibiotics Market: DNA Synthesis Inhibitors, 2019-2030, USD mn 57

Figure 29. Global Oral Antibiotics Market: Protein Synthesis Inhibitors, 2019-2030, USD mn 58

Figure 30. Global Oral Antibiotics Market: Other Mechanisms, 2019-2030, USD mn 59

Figure 31. Breakdown of Global Oral Antibiotics Market by Drug Origin, 2019-2030, % of Sales Revenue 61

Figure 32. Global Addressable Market Cap in 2020-2030 by Drug Origin, Value (USD mn) and Share (%) 61

Figure 33. Global Oral Antibiotics Market: Natural Antibiotics, 2019-2030, USD mn 62

Figure 34. Global Oral Antibiotics Market: Semi-synthetic Antibiotics, 2019-2030, USD mn 63

Figure 35. Global Oral Antibiotics Market: Synthetic Antibiotics, 2019-2030, USD mn 64

Figure 36. Breakdown of Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, % of Revenue 66

Figure 37. Global Addressable Market Cap in 2020-2030 by Activity Spectrum, Value (USD mn) and Share (%) 66

Figure 38. Global Oral Antibiotics Market: Broad-spectrum Antibiotics, 2019-2030, USD mn 67

Figure 39. Global Oral Antibiotics Market: Narrow-spectrum Antibiotics, 2019-2030, USD mn 68

Figure 40. Breakdown of Global Oral Antibiotics Market by Application, 2019-2030, % of Revenue 70

Figure 41. Global Addressable Market Cap in 2020-2030 by Application, Value (USD mn) and Share (%) 70

Figure 42. Global Oral Antibiotics Market: Urinary Tract Infections (UTIS), 2019-2030, USD mn 71

Figure 43. Global Oral Antibiotics Market: Dental Infections, 2019-2030, USD mn 72

Figure 44. Global Oral Antibiotics Market: Monotherapies for Dental Infections, 2019-2030, USD mn 73

Figure 45. Global Oral Antibiotics Market: Combined Therapies for Dental Infections, 2019-2030, USD mn 74

Figure 46. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS), 2019-2030, USD mn 75

Figure 47. Global Oral Antibiotics Market: Upper Respiratory Tract Infections (URTI), 2019-2030, USD mn 76

Figure 48. Global Oral Antibiotics Market: Lower Respiratory Tract Infections (LRTIs), 2019-2030, USD mn 77

Figure 49. Global Oral Antibiotics Market: Other Applications, 2019-2030, USD mn 78

Figure 50. Breakdown of Global Oral Antibiotics Market by Drug Type, 2019-2030, % of Revenue 79

Figure 51. Global Addressable Market Cap in 2020-2030 by Drug Type, Value (USD bn) and Share (%) 80

Figure 52. Global Oral Antibiotics Market: Brand Antibiotics, 2019-2030, USD bn 81

Figure 53. Global Oral Antibiotics Market: Generic Antibiotics, 2019-2030, USD bn 82

Figure 54. Global Market Snapshot by Region 83

Figure 55. Geographic Spread of Worldwide Oral Antibiotics Market, 2019-2030, % of Sales Revenue 84

Figure 56. Global Addressable Market Cap in 2020-2030 by Region, Value (USD bn) and Share (%) 85

Figure 57. Health Spending as a Share of GDP by Country, 2015 and 2030 87

Figure 58. North American Oral Antibiotics Market, 2019-2030, USD bn 90

Figure 59. Breakdown of North America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 91

Figure 60. Contribution to North America 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 92

Figure 61. U.S. Oral Antibiotics Market, 2019-2030, USD bn 94

Figure 62. Rising Incidence of Infectious Disease in U.S. 94

Figure 63. Canada Oral Antibiotics Market, 2019-2030, USD bn 97

Figure 64. Oral Antibiotics Market in Mexico, 2015-2030, USD bn 99

Figure 65. European Oral Antibiotics Market, 2019-2030, USD bn 102

Figure 66. Breakdown of European Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 103

Figure 67. Contribution to Europe 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 104

Figure 68. Oral Antibiotics Market in Germany, 2019-2030, USD bn 105

Figure 69. Oral Antibiotics Market in UK, 2019-2030, USD bn 107

Figure 70. Oral Antibiotics Market in France, 2019-2030, USD bn 109

Figure 71. Oral Antibiotics Market in Spain, 2019-2030, USD bn 111

Figure 72. Oral Antibiotics Market in Italy, 2019-2030, USD bn 113

Figure 73. Oral Antibiotics Market in Russia, 2019-2030, USD bn 115

Figure 74. Oral Antibiotics Market in Rest of Europe, 2019-2030, USD bn 117

Figure 75. Asia-Pacific Oral Antibiotics Market, 2019-2030, USD bn 120

Figure 76. Breakdown of APAC Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 120

Figure 77. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 122

Figure 78. Oral Antibiotics Market in Japan, 2019-2030, USD bn 124

Figure 79. Oral Antibiotics Market in China, 2019-2030, USD bn 126

Figure 80. Oral Antibiotics Market in Australia, 2019-2030, USD bn 128

Figure 81. Oral Antibiotics Market in India, 2019-2030, USD bn 130

Figure 82. Oral Antibiotics Market in South Korea, 2019-2030, USD bn 132

Figure 83. Oral Antibiotics Market in Rest of APAC, 2019-2030, USD bn 134

Figure 84. South America Oral Antibiotics Market, 2019-2030, USD bn 137

Figure 85. Breakdown of South America Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 137

Figure 86. Contribution to South America 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 138

Figure 87. Oral Antibiotics Market in Argentina, 2019-2030, USD bn 139

Figure 88. Oral Antibiotics Market in Brazil, 2019-2030, USD bn 141

Figure 89. Oral Antibiotics Market in Chile, 2019-2030, USD bn 143

Figure 90. Oral Antibiotics Market in Rest of South America, 2019-2030, USD bn 145

Figure 91. Oral Antibiotics Market in Middle East and Africa (MEA), 2019-2030, USD bn 147

Figure 92. Breakdown of MEA Oral Antibiotics Market by Country, 2019 and 2030, % of Revenue 147

Figure 93. Contribution to MEA 2020-2030 Cumulative Revenue by Country, Value (USD bn) and Share (%) 148

Figure 94. Oral Antibiotics Market in UAE, 2019-2030, USD bn 149

Figure 95. Oral Antibiotics Market in Saudi Arabia, 2019-2030, USD bn 151

Figure 96. Oral Antibiotics Market in South Africa, 2019-2030, USD bn 153

Figure 97. Growth Stage of Global Oral Antibiotics Industry over the Forecast Period 156


List of Table

Table 1. Snapshot of Global Oral Antibiotics Market, 2019-2030 21

Table 2. Main Product Trends and Market Opportunities in Global Oral Antibiotics Market 33

Table 3. Global Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 41

Table 4. Global Oral Antibiotics Market: Cephalosporin by Molecule, 2019-2030, USD mn 44

Table 5. Global Oral Antibiotics Market by Action Mechanism, 2019-2030, USD mn 52

Table 6. Global Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 60

Table 7. Global Oral Antibiotics Market by Activity Spectrum, 2019-2030, USD mn 65

Table 8. Global Oral Antibiotics Market by Application, 2019-2030, USD mn 69

Table 9. Global Oral Antibiotics Market: Dental Infections by Type, 2019-2030, USD mn 72

Table 10. Global Oral Antibiotics Market: Respiratory Tract Infections (RTIS) by Type, 2019-2030, USD mn 75

Table 11. Global Oral Antibiotics Market by Drug Type, 2019-2030, USD bn 79

Table 12. Global Oral Antibiotics Market by Region, 2019-2030, USD bn 84

Table 13. Total Health Expenditure per capita in PPP International U.S. Dollars by Country 86

Table 14. Leading National Oral Antibiotics Market, 2019 and 2030, USD bn 88

Table 15. North America Oral Antibiotics Market by Country, 2019-2030, USD bn 91

Table 16. U.S. Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 95

Table 17. U.S. Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 95

Table 18. U.S. Oral Antibiotics Market by Application, 2019-2030, USD mn 95

Table 19. Canada Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 98

Table 20. Canada Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 98

Table 21. Canada Oral Antibiotics Market by Application, 2019-2030, USD mn 98

Table 22. Mexico Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 100

Table 23. Mexico Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 100

Table 24. Mexico Oral Antibiotics Market by Application, 2019-2030, USD mn 100

Table 25. Europe Oral Antibiotics Market by Country, 2019-2030, USD bn 104

Table 26. Germany Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 106

Table 27. Germany Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 106

Table 28. Germany Oral Antibiotics Market by Application, 2019-2030, USD mn 106

Table 29. UK Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 108

Table 30. UK Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 108

Table 31. UK Oral Antibiotics Market by Application, 2019-2030, USD mn 108

Table 32. France Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 110

Table 33. France Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 110

Table 34. France Oral Antibiotics Market by Application, 2019-2030, USD mn 110

Table 35. Spain Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 112

Table 36. Spain Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 112

Table 37. Spain Oral Antibiotics Market by Application, 2019-2030, USD mn 112

Table 38. Italy Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 114

Table 39. Italy Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 114

Table 40. Italy Oral Antibiotics Market by Application, 2019-2030, USD mn 114

Table 41. Russia Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 116

Table 42. Russia Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 116

Table 43. Russia Oral Antibiotics Market by Application, 2019-2030, USD mn 116

Table 44. Oral Antibiotics Market in Rest of Europe by Country, 2019-2030, USD bn 118

Table 45. APAC Oral Antibiotics Market by Country, 2019-2030, USD bn 121

Table 46. Japan Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 125

Table 47. Japan Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 125

Table 48. Japan Oral Antibiotics Market by Application, 2019-2030, USD mn 125

Table 49. China Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 127

Table 50. China Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 127

Table 51. China Oral Antibiotics Market by Application, 2019-2030, USD mn 127

Table 52. Australia Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 129

Table 53. Australia Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 129

Table 54. Australia Oral Antibiotics Market by Application, 2019-2030, USD mn 129

Table 55. India Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 131

Table 56. India Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 131

Table 57. India Oral Antibiotics Market by Application, 2019-2030, USD mn 131

Table 58. South Korea Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 133

Table 59. South Korea Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 133

Table 60. South Korea Oral Antibiotics Market by Application, 2019-2030, USD mn 133

Table 61. Oral Antibiotics Market in Rest of APAC by Country, 2019-2030, USD bn 135

Table 62. South America Oral Antibiotics Market by Country, 2019-2030, USD bn 138

Table 63. Argentina Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 140

Table 64. Argentina Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 140

Table 65. Argentina Oral Antibiotics Market by Application, 2019-2030, USD mn 140

Table 66. Brazil Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 142

Table 67. Brazil Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 142

Table 68. Brazil Oral Antibiotics Market by Application, 2019-2030, USD mn 142

Table 69. Chile Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 144

Table 70. Chile Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 144

Table 71. Chile Oral Antibiotics Market by Application, 2019-2030, USD mn 144

Table 72. MEA Oral Antibiotics Market by Country, 2019-2030, USD bn 148

Table 73. UAE Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 150

Table 74. UAE Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 150

Table 75. UAE Oral Antibiotics Market by Application, 2019-2030, USD mn 150

Table 76. Saudi Arabia Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 152

Table 77. Saudi Arabia Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 152

Table 78. Saudi Arabia Oral Antibiotics Market by Application, 2019-2030, USD mn 152

Table 79. South Africa Oral Antibiotics Market by Drug Class, 2019-2030, USD mn 154

Table 80. South Africa Oral Antibiotics Market by Drug Origin, 2019-2030, USD mn 154

Table 81. South Africa Oral Antibiotics Market by Application, 2019-2030, USD mn 154

Table 82. Breakdown of Global Market by Key Vendor, 2019, % 158

Table 83. Abbott Laboratories: Company Snapshot 161

Table 84. Abbott Laboratories: Business Segmentation 161

Table 85. Abbott Laboratories: Product Portfolio 162

Table 86. Abbott Laboratories: Revenue, 2016-2018, USD mn 162

Table 87. Abbott Laboratories: Recent Developments 162

Table 88. Risk Evaluation for Investing in Global Market, 2019-2030 182

Table 89. Critical Success Factors and Key Takeaways 185

You can also purchase parts of this report. Do you want to check out a section wise price list?

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022

What Our Clients Say About Us

Want the same for your business? Talk To Our Expert